In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro ...

President Trump shared an anecdote about a wealthy friend's experience with inflated drug prices in the U.S., prompting a ...

WGN’s Dina Bair has the latest on new medical information, including: Study: Mounjaro helped people achieve more weight loss ...

A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

Fashion and beauty’s new appetite for collaborating with food brands collides with a worrying return to ’90s-era thinness and ...

Metamorphx is emerging as a leading natural GLP-1 alternative for weight loss in 2025. With prescription options like ...

Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...

With Wegovy in its portfolio, Novo Nordisk is a very good bet to continue being a winner. As it's currently considered something of an underdog, with its stock priced accordingly, it's also trading at ...

The pharmaceutical firm Novo Nordisk is pursuing a multipronged strategy to regain market share that it has lost to Eli Lilly ...

Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent ...

When products like Novo Nordisk's semaglutides Ozempic and Wegovy and Eli Lilly's tirzepatides Zepbound and Mounjaro became ... as self-pay drugs at huge discounts while insurance companies ...